AXSM - Axsome Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-30,965.464-28,943.392-27,201.653-12,210.579
Operating Activities, Cash Flows Provided By or Used In
Depreciation48.93542.55720.4843.542
Adjustments To Net Income-1,036.0262,718.212,031.4183,822.562
Changes In Accounts Receivables----
Changes In Liabilities251.789-645.7172,188.811,134.204
Changes In Inventories----
Changes In Other Operating Activities1,271.43-113.8311,610.707-196.477
Total Cash Flow From Operating Activities-30,053.701-26,471.652-21,281.304-7,438.991
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-32.696-9.898-104.561-20.195
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-32.696-9.898-104.561-20.195
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-3,333.333-277.77810,0007,340.999
Other Cash Flows from Financing Activities-25.997-25.997-64.928-12.489
Total Cash Flows From Financing Activities10,034.01623,884.1769,968.10252,877.631
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-20,052.381-2,597.374-11,417.76345,418.445